By using our website you agree to our use of cookies in accordance with our cookie policy.
Okay
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider.
Show more
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs, FX or any of our other products work and whether you can afford to take the high risk of losing your money.
Show less
TradersInstitutional and Partners
General.Accessibility.Close

Quick Links

FOREX 5 minutes to read

Bullard rains on the USD bears’ parade

John Hardy
Head of FX Strategy
Read More
    FOREX

    Forex is the next trade war frontier

    Steen Jakobsen
    President Trump's insatiable appetite for new 'enemies' (China, EU, news media, immigrants,) has found a new trade war target – foreign exchange. The upshot will be a weaker dollar and US bond yields heading towards zero.
    MORNING CALL

    Morning Call: Nasdaq 100 corrects

    Clare MacCarthy
    In today's edition of the Saxo Morning Call, we look at how the US' leading tech equity index has been knocked back by a mix of Iran worries, the US charges against some Chinese banks and the fact we're hitting the end of the quarter. Gold, too, has fallen off its perch over St Louis Fed president James Bullard's remark that a 50bps rate cut "would be excessive".
    FOREX

    Bullard rains on the USD bears’ parade

    John Hardy
    The St. Louis Fed’s Bullard rained on the USD bears’ parade by suggesting support for a 25-bps cut at the July FOMC meeting, which kept Fed expectations flat even as Fed chair Powell confirmed a cutting bias and US equities were in for rough sledding yesterday.
    FOREX

    AbbVie puckers up for Botox-maker

    Michael O’Neill
    Big pharma is hitting the headlines today after AbbVie Inc (ABBV: NYSE) puckered up, then ponied up $63.0 billion in cash and stock to acquire Botox-maker Allergan (AGN: NYSE).
    MACRO

    The US/China power struggle is far from over

    Eleanor Creagh
    Markets are in limbo as traders and investors await the much-anticipated meeting between Chinese leader, Xi Jinping and US President Donald Trump, the outcome of which could dictate the tone of trading over the Northern hemisphere summer.
    MACRO

    When's the next Aussie rate cut?

    Eleanor Creagh
    The increasingly poor state of the Australian economy and the Reserve Bank's failure to meet its objectives, combine to make another rate cut inevitable. But the market is split on whether this will happen in July or August.
    FOREX OPTIONS

    FX Options Update: June 25, 2019

    Dan Larsen
    Saxo Bank's latest report on the FX Options space is now live, with a look at how vols are picking up a bid over the increased tension between the US and Iran as well as the G20 meeting this weekend.
    FOREX

    Another Powell speech and quarter end coming up

    John Hardy
    The USD sell-off has run out of steam a bit ahead of a speech with Q&A from Fed Chair Powell late today. Ahead of quarter end, we wonder if portfolio reallocations could heavily swing price action in coming sessions, given large moves in especially bonds over the last quarter.
    Load more

    Disclaimer

    The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

    Please read our disclaimers:
    - Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
    - Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)